Impact of Mannitol Administration on Postoperative Renal Function After Robot-Assisted Partial Nephrectomy

Area of Science:

• Nephrology
• Urology
• Surgical Oncology

Background:

• Robot-assisted partial nephrectomy (RAPN) is a standard treatment for renal cell carcinoma (RCC).
• The use of mannitol during RAPN to preserve renal function is debated.
• This study evaluates mannitol's impact on postoperative kidney function in RCC patients undergoing RAPN.

Purpose of the Study:

• To determine if intraoperative mannitol administration affects postoperative renal function in patients undergoing RAPN for RCC.
• To compare perioperative outcomes between patients who received mannitol and those who did not.

Main Methods:

• A retrospective study involving 1530 patients with RCC who underwent RAPN across eight Japanese facilities.
• Propensity score matching (PSM) was used to create comparable groups: mannitol administration (Group I) and no mannitol (Group II).
• Evaluated perioperative outcomes including length of stay, surgical results, Trifecta achievement, and estimated glomerular filtration rate (eGFR) at multiple time points.

Main Results:

• After PSM, 531 patients were analyzed in each group.
• No significant differences were found in length of hospital stay, surgical outcomes, or Trifecta achievement between the mannitol and no-mannitol groups.
• Postoperative eGFR at 28 days, 90 days, and 1 year showed no difference between the two groups.

Conclusions:

• Intraoperative mannitol administration during RAPN for RCC does not appear to improve postoperative renal function.
• The findings suggest that mannitol may not be a necessary adjunct for preserving renal function in this patient population.
• Further research may explore alternative renoprotective strategies during RAPN.